PTAB Denies Institution of IPRs of HUMIRA™ Patents

Jan 21, 2016

Reading Time : 1 min

By: Michael P. Kahn

Amgen, Inc. v. AbbVie Biotechnology LTD., IPR2015­01514 (PTAB January 14, 2015)[Elluru (opinion), Hulse, LaVier].

Amgen, Inc. v. AbbVie Biotechnology LTD., IPR2015­01517 (PTAB January 14, 2015)[LaVier (opinion), Elluru, Hulse].

Share This Insight

Categories

35 U.S.C. § 103Patent Trial & Appeal BoardInter Partes Review

Previous Entries